[1] |
Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2024,74:229-263. doi: 10.3322/caac.21834.
|
[2] |
Machlowska J, Baj J, Sitarz M, et al. Gastric cancer: epidemiology, risk factors, classification, genomic characteristics and treatment strategies[J]. Int J Mol Sci, 2020,21:4012. doi:10.3390/ijms21114012.
|
[3] |
Yan H, Bu P. Non-coding RNA in cancer[J]. Essays Biochem,2021,65:625-639.
|
[4] |
肖宁,林玮键,龙永福.长链非编码RNA HIF1A-AS1的研究现状与进展[J].现代医学与健康研究电子杂志,2021,5:126-128.
|
[5] |
Hong F, Gao Y, Li Y, et al. Inhibition of HIF1A-AS1 promoted starvation-induced hepatocellular carcinoma cell apoptosis by reducing HIF-1α/mTOR-mediated autophagy[J]. World J Surg Oncol, 2020,18:113.doi: 10.1186/s12957-020-01884-x.
|
[6] |
Xu J, Zhang Y, Chu L, et al. Long non-coding RNA HIF1A-AS1 is upregulated in intracranial aneurysms and participates in the regulation of proliferation of vascular smooth muscle cells by upregulating TGF-β1[J]. Exp Ther Med, 2019,17:1797-1801.doi: 10.3892/etm.2018.7144.
|
[7] |
Gao J, Cao R, Mu H. Long non-coding RNA UCA1 may be a novel diagnostic and predictive biomarker in plasma for early gastric cancer[J]. Int J Clin Exp Pathol, 2015,8:12936-12942.
|
[8] |
Gong Z, Yang J, Dong J, et al. LncRNA HIF1A-AS1 regulates the cellular function of HUVECs by globally regulating mRNA and miRNA expression[J]. Front Biosci (Landmark Ed), 2022,27:330. doi: 10.31083/j.fbl2712330.
|
[9] |
Gong W, Tian M, Qiu H, et al. Elevated serum level of lncRNA-HIF1A-AS1 as a novel diagnostic predictor for worse prognosis in colorectal carcinoma[J]. Cancer Biomark, 2017,20:417-424. doi: 10.3233/CBM-170179.
|
[10] |
Tantai J, Hu D, Yang Y, et al. Combined identification of long non-coding RNA XIST and HIF1A-AS1 in serum as an effective screening for non-small cell lung cancer[J]. Int J Clin Exp Pathol, 2015,8:7887-7895.
|
[11] |
Chen D, Wu L, Liu L, et al. Comparison of HIF1A-AS1 and HIF1A-AS2 in regulating HIF-1α and the osteogenic differentiation of PDLCs under hypoxia[J]. Int J Mol Med, 2017,40:1529-1536. doi: 10.3892/ijmm.2017.3138.
|
[12] |
Tantai J, Hu D, Yang Y, et al. Combined identification of long non-coding RNA XIST and HIF1A-AS1 in serum as an effective screening for non-small cell lung cancer[J]. Int J Clin Exp Pathol, 2015,8:7887-7895.
|
[19] |
张广健,高蕊,付军科,等. 多药耐药基因及缺氧诱导因子-1α在食管癌组织中的表达及其临床意义[J]. 西安交通大学学报(医学版), 2010, 31: 724-727.
|
[20] |
Rashid M, Zadeh LR, Baradaran B, et al. Up-down regulation of HIF-1α in cancer progression[J]. Gene, 2021,798:145796. doi: 10.1016/j.gene.2021.145796.
|
[14] |
Maruggi M, Layng FI, Lemos R Jr, et al. Absence of HIF1A leads to glycogen accumulation and an inflam-matory response that enables pancreatic tumor growth[J]. Cancer Res, 2019,79:5839-5848. doi: 10.1158/0008-5472.CAN-18-2994.
|
[15] |
金烨,颜海豪,代璐,等.缺氧诱导因子-1在胃癌中的研究进展[J].中国临床研究,2021,34:405-408.
|